Metabolic plasticity in resting and thrombin activated platelets.

Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that...

Full description

Bibliographic Details
Main Authors: Saranya Ravi, Balu Chacko, Hirotaka Sawada, Philip A Kramer, Michelle S Johnson, Gloria A Benavides, Valerie O'Donnell, Marisa B Marques, Victor M Darley-Usmar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395425?pdf=render
id doaj-ab466e185cc64b3b8f68f2bb25048a1e
record_format Article
spelling doaj-ab466e185cc64b3b8f68f2bb25048a1e2020-11-24T21:11:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012359710.1371/journal.pone.0123597Metabolic plasticity in resting and thrombin activated platelets.Saranya RaviBalu ChackoHirotaka SawadaPhilip A KramerMichelle S JohnsonGloria A BenavidesValerie O'DonnellMarisa B MarquesVictor M Darley-UsmarPlatelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.http://europepmc.org/articles/PMC4395425?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Saranya Ravi
Balu Chacko
Hirotaka Sawada
Philip A Kramer
Michelle S Johnson
Gloria A Benavides
Valerie O'Donnell
Marisa B Marques
Victor M Darley-Usmar
spellingShingle Saranya Ravi
Balu Chacko
Hirotaka Sawada
Philip A Kramer
Michelle S Johnson
Gloria A Benavides
Valerie O'Donnell
Marisa B Marques
Victor M Darley-Usmar
Metabolic plasticity in resting and thrombin activated platelets.
PLoS ONE
author_facet Saranya Ravi
Balu Chacko
Hirotaka Sawada
Philip A Kramer
Michelle S Johnson
Gloria A Benavides
Valerie O'Donnell
Marisa B Marques
Victor M Darley-Usmar
author_sort Saranya Ravi
title Metabolic plasticity in resting and thrombin activated platelets.
title_short Metabolic plasticity in resting and thrombin activated platelets.
title_full Metabolic plasticity in resting and thrombin activated platelets.
title_fullStr Metabolic plasticity in resting and thrombin activated platelets.
title_full_unstemmed Metabolic plasticity in resting and thrombin activated platelets.
title_sort metabolic plasticity in resting and thrombin activated platelets.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.
url http://europepmc.org/articles/PMC4395425?pdf=render
work_keys_str_mv AT saranyaravi metabolicplasticityinrestingandthrombinactivatedplatelets
AT baluchacko metabolicplasticityinrestingandthrombinactivatedplatelets
AT hirotakasawada metabolicplasticityinrestingandthrombinactivatedplatelets
AT philipakramer metabolicplasticityinrestingandthrombinactivatedplatelets
AT michellesjohnson metabolicplasticityinrestingandthrombinactivatedplatelets
AT gloriaabenavides metabolicplasticityinrestingandthrombinactivatedplatelets
AT valerieodonnell metabolicplasticityinrestingandthrombinactivatedplatelets
AT marisabmarques metabolicplasticityinrestingandthrombinactivatedplatelets
AT victormdarleyusmar metabolicplasticityinrestingandthrombinactivatedplatelets
_version_ 1716754720116178944